Newsletter Archive

1. 05.20.19 -- A Technology Roadmap For Today's Gene Therapy Manufacturing Challenges
   5/20/2019
   05/20/19 BioProcess Online Newsletter
2. 05.16.19 -- Biopharma Research, Development, And Manufacturing
   5/16/2019
   05/16/19 BioProcess Online Newsletter
3. 05.15.19 -- Analysis Of The Trastuzumab Biosimilar Market As Herceptin Exclusivity Nears An End
   5/15/2019
   05/15/19 BioProcess Online Newsletter
4. 05.14.19 -- Minimizing Risk In Pharmaceutical Logistics
   5/14/2019
   05/14/19 BioProcess Online Newsletter
5. 05.13.19 -- Refrigerated Transport For Gene Therapy Products
   5/13/2019
   05/13/19 BioProcess Online Newsletter
6. 05.08.19 -- An Introduction To Centerlining For Biopharma Manufacturing
   5/8/2019
   05/08/19 BioProcess Online Newsletter
7. 05.06.19 -- Toward A More Robust Regenerative Medicine Regulatory Pathway
   5/6/2019
   05/06/19 BioProcess Online Newsletter
8. 05.01.19 -- What's In A Name? FDA Proposes Updates To Biosimilar Naming Policy
   5/1/2019
   05/01/19 BioProcess Online Newsletter
9. 04.29.19 -- Controlling Bioburden: Cleaning, Sanitizing, Sterilizing, Or Wishing It Away?
   4/29/2019
   04/29/19 BioProcess Online Newsletter
10. 04.24.19 -- The Unique Demands Of Cell And Gene Therapy Supply Chains
    4/24/2019
    04/24/19 BioProcess Online Newsletter